Literature DB >> 35501461

Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling.

Kai Li1,2, Yi Niu1, Yichuan Yuan1,2, Jiliang Qiu1,2, Yunxing Shi1,2, Chengrui Zhong1,2, Zhiyu Qiu1,2, Keren Li1,2, Zhu Lin1,2, Zhenkun Huang1,2, Chao Zhang1,3, Dinglan Zuo1, Wei He1,2, Yunfei Yuan4,5, Binkui Li6,7.   

Abstract

Thermal ablation is a main curative therapy for early-stage hepatocellular carcinoma (HCC). However, insufficient ablation has been shown to promote HCC progression. E3 ligases have been approved to play important roles in malignant tumors. Whether E3 ligases are involved in HCC progression caused by insufficient ablation remains unclear. Herein, using RNA-sequencing coupled with an in vitro loss-of-function screen, we found that the E3 ligase Neuronal Precursor cell-expressed Developmentally Downregulated 4 (Nedd4) was upregulated in HCC insufficient ablation tissues and promoted HCC cells migration. The upregulation of Nedd4 was induced by METTL14-mediated N6-methyladenosine modification after sublethal heat treatment. Knockdown of Nedd4 inhibited HCC metastasis and growth in vitro and in vivo. Mechanistically, Nedd4 enhanced TGF-β signal transduction mediated tumor progression by directly binding to TGF-β type I receptor (TGFBR1) and forming K27-linked ubiquitin at Lysine 391. Additionally, the adverse effect on HCC of sublethal heat treatment was mediated by Nedd4. Clinically, high Nedd4 expression was positively correlated with aggressive tumor phenotypes and poor prognosis in HCC patients. Patient-derived xenograft (PDX) model confirmed this conclusion. Collectively, this study demonstrated that Nedd4 induced by insufficient ablation plays a crucial role in promoting HCC progression and provides a novel therapeutic target for HCC.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35501461     DOI: 10.1038/s41388-022-02334-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  46 in total

1.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules.

Authors:  P J Lu; X Z Zhou; M Shen; K P Lu
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

Review 2.  Ubiquitination in disease pathogenesis and treatment.

Authors:  Doris Popovic; Domagoj Vucic; Ivan Dikic
Journal:  Nat Med       Date:  2014-11-06       Impact factor: 53.440

3.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

Review 4.  Functions and mechanisms of non-histone protein acetylation.

Authors:  Takeo Narita; Brian T Weinert; Chunaram Choudhary
Journal:  Nat Rev Mol Cell Biol       Date:  2019-03       Impact factor: 94.444

Review 5.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

Review 6.  Ubiquitylation at the crossroads of development and disease.

Authors:  Michael Rape
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-20       Impact factor: 94.444

Review 7.  Protein O-GlcNAcylation: emerging mechanisms and functions.

Authors:  Xiaoyong Yang; Kevin Qian
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

8.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

9.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

10.  Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells.

Authors:  Jing Jing Li; Ruishan Wang; Rati Lama; Xinjiang Wang; Z Elizabeth Floyd; Edwards A Park; Francesca-Fang Liao
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.